Background: Clostridium difficile (CD) is the most common pathogen causing nosocomial diarrhea. The clinical presentation ranges from mild diarrhea to severe complications, including pseudomembranous colitis, toxic megacolon, sepsis, and multi-organ failure. When the disease takes a fulminant course, death ensues rapidly in severe and complex cases. Preventive screening or current prophylactic therapies are not useful. Therefore, this study was conducted to detect risk factors for a fulminant CD infection (CDI) in patients undergoing cardiac surgery.

Methods: Between April 1999 and April 2011, a total of 41,466 patients underwent cardiac surgery at our institution. A review of our hospital database revealed 1256 patients (3.0%) with post-operative diarrheal disease who tested positive for CD; these patients comprised the cohort of this observational study. A fulminant CDI occurred in 153 of these patients (12.2%), which was diagnosed on the basis of gastrointestinal complications, e.g. pseudomembranous colitis, and/or the need for post-cardiac surgery laparotomy. Demographic, peri-operative, and survival data were analyzed, and predictors of a fulminant CDI were assessed by binary logistic regression analysis.

Results: The 30-day mortality was 6.1% (n = 77) for the entire cohort, with significantly higher mortality among patients with a fulminant CDI (21.6% vs. 4.0%, p <  0.001). Overall mortality (27.7%, n = 348) was also higher for patients with a fulminant course of the disease (63.4% vs. 22.8%, p <  0.001), and a laparotomy was required in 36.6% (n = 56) of the fulminant cases. Independent predictors of a fulminant CDI were: diabetes mellitus type 2 (OR 1.74, CI 1.15-2.63, p = 0.008), pre-operative ventilation (OR 3.52, CI 1.32-9.35, p = 0.012), utilization of more than 8 units of red blood cell concentrates (OR 1.95, CI 1.01-3.76, p = 0.046) or of more than 5 fresh-frozen plasma units (OR 3.38, CI 2.06-5.54, p <  0.001), and a cross-clamp time > 130 min (OR 1.93, CI 1.12-3.33, p = 0.017).

Conclusions: We identified several independent risk factors for the development of a fulminant CDI after cardiac surgery. Close monitoring of high-risk patients is important in order to establish an early onset of therapy and thus to prevent a CDI from developing a fulminant course after cardiac surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158878PMC
http://dx.doi.org/10.1186/s12871-018-0597-2DOI Listing

Publication Analysis

Top Keywords

fulminant cdi
12
risk factors
8
factors fulminant
8
clostridium difficile
8
cardiac surgery
8
pseudomembranous colitis
8
fulminant
6
patients
6
evaluation risk
4
fulminant clostridium
4

Similar Publications

Clostridioides (Clostridium) difficile (C. difficile) infection (CDI), often severe when producing toxin A, toxin B, and CDT, can cause life-threatening fulminant infections, especially in vulnerable patients. This case report discusses a 39-year-old woman with no medical history who developed severe CDI after antibiotic treatment, leading to fatal hypovolemic shock.

View Article and Find Full Text PDF

The laboratory diagnosis of infection (CDI) is controversial. Nucleic acid amplification tests (NAAT) and toxin enzyme immunoassays (EIA) are most widely used, often in combination. However, the interpretation of a positive NAAT and negative toxin immunoassay (NAAT+/EIA-) is uncertain.

View Article and Find Full Text PDF

Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infection.

Int J Infect Dis

February 2025

Henry Ford Hospital, Department of Pharmacy, Detroit, USA; Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Department of Pharmacy Practice, Detroit, USA.

Article Synopsis
  • - This study aimed to evaluate the effectiveness of eravacycline (ERV) as an additional treatment for severe or fulminant Clostridioides difficile infection (CDI) in hospitalized patients from 2019 to 2023.
  • - A total of 75 patients were analyzed, with a significant portion suffering from severe or fulminant CDI, and approximately 14.7% required colectomy within 30 days of starting ERV treatment.
  • - The findings suggest that ERV could be a beneficial adjunct therapy for severe CDI, especially in immunocompromised patients, but further research is needed to confirm its effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • Clostridioides difficile infection (CDI) is a major cause of infectious diarrhea, and this study evaluates the effects of early antibiotic treatment on patient outcomes like mortality and hospital stay duration.
  • The study analyzed data from 796 adult CDI patients and found that starting treatment within 24 hours of stool sampling did not significantly improve mortality rates or recurrence compared to later treatment.
  • However, early treatment did lead to a shorter average hospital stay of 6 days compared to 8 days, indicating some benefit in terms of hospital resource use.*
View Article and Find Full Text PDF

Introduction: infection (CDI) is a common nosocomial infection and is associated with a high healthcare burden due to high rates of recurrence. In 2021 the IDSA/SHEA guideline update recommended fidaxomicin (FDX) as first-line therapy. Our medical center updated our institutional guidelines to follow these recommendations, prioritizing FDX use among patients at high risk for recurrent CDI (rCDI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!